Matrix metalloproteinase-9 increases and interleukin-10 reduces with increase in body mass index in polycystic ovary syndrome: A cross-sectional study

5Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Background: Obesity, inflammation and alterations in matrix metalloproteinase-9 (MMP-9) and nitric oxide (NO) levels are involved in the development of polycystic ovary syndrome (PCOS). Objective: To investigate the relationship of MMP-9, NO and interleukin-10 (IL-10) with the increase in body mass index (BMI) in women with PCOS. Materials and Methods: Sixty two infertile PCOS women were included in the study. Serum levels of NO, IL-10 and MMP-9 were assessed in the women with increase in BMI. Results: MMP-9 was significantly increased (p = 0.029) and IL-10 (p = 0.015) was significantly reduced in obese PCOS subjects compared to those with lesser BMI. MMP-9 levels positively correlated with the duration of infertility (r = 0.253, p = 0.047) and negatively correlated with NO levels (r =-0.259, p = 0.042). A significant negative correlation between the interleukin-10 levels and the BMI (r =-0.272, p = 0.033) was also found in the PCOS subjects. Conclusion: MMP-9 levels are increased in obese PCOS women and it is associated with NO levels and the duration of infertility.

Cite

CITATION STYLE

APA

Sylus, A. M., Nandeesha, H., & Chitra, T. (2020). Matrix metalloproteinase-9 increases and interleukin-10 reduces with increase in body mass index in polycystic ovary syndrome: A cross-sectional study. International Journal of Reproductive BioMedicine, 18(8), 605–610. https://doi.org/10.18502/ijrm.v13i8.7502

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free